Biphasic mixtures of GLP-1 and insulin

Details Biphasic mixtures of GLP-1 and insulin Biphasic mixtures of GLP-1 and insulin

2007-02-20

2007-02-20

Gupta, Anish (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S012200, C530S303000, C530S308000

Reexamination Certificate

active

10490575

ABSTRACT:
The present invention encompasses pharmaceutical formulations comprising a biphasic mixture which comprises a glucagon like peptide (GLP-1) compound in a solid phase and an insulin in a solution phase.

REFERENCES:
patent: 5118666 (1992-06-01), Habener
patent: 5120712 (1992-06-01), Habener
patent: 5461031 (1995-10-01), De Felippis
patent: 5512549 (1996-04-01), Chen et al.
patent: 5514646 (1996-05-01), Chance et al.
patent: 5545618 (1996-08-01), Buckley et al.
patent: 5547929 (1996-08-01), Anderson, Jr. et al.
patent: 5650486 (1997-07-01), De Felippis
patent: 5656722 (1997-08-01), Dorschug
patent: 5705483 (1998-01-01), Galloway et al.
patent: 5747642 (1998-05-01), De Felippis
patent: 5840680 (1998-11-01), Balschmidt
patent: 5948751 (1999-09-01), Kimer et al.
patent: 5977071 (1999-11-01), Galloway et al.
patent: 6011007 (2000-01-01), Havelund et al.
patent: 6133235 (2000-10-01), Galloway et al.
patent: 6191102 (2001-02-01), DiMarchi et al.
patent: 6221633 (2001-04-01), Ertl et al.
patent: 6221837 (2001-04-01), Ertl et al.
patent: 6268343 (2001-07-01), Knudsen et al.
patent: 6277877 (2001-08-01), Hoover et al.
patent: 2001/0047084 (2001-11-01), Knudsen et al.
patent: WO 93/18786 (1993-09-01), None
patent: WO 95/07931 (1995-03-01), None
patent: WO 95/31214 (1995-11-01), None
patent: WO 99/07404 (1999-02-01), None
patent: WO 99/25727 (1999-05-01), None
patent: WO 99/25728 (1999-05-01), None
patent: WO 99/32116 (1999-07-01), None
patent: WO 99/43708 (1999-09-01), None
patent: WO 00/37098 (2000-06-01), None
patent: WO 00/66629 (2000-11-01), None
patent: WO 01/00223 (2001-01-01), None
patent: WO 03/053339 (2003-07-01), None
DeFelippis et al. ‘Preparation and Characterization of a Cocrystalline Suspension of [LYSB28, PROB29]-Human Insulin Analogue’, J. of Pharm. Sci. vol. 87, No. 2, Feb. 1998, pp. 170-176.
Adelhorst, et al., “Structure-Activity Studies of Glucagon-Like Peptide-1.” 1994, J. Biological Chemistry vol. 269: 6275-6278.
Brange, “Galenics of Insulin: The Physico-chemical and Pharmaceutical Aspects of Insulin and Insulin Preparation.” 1987.
Markussen, et al., “Soluble, Prolonged-acting Insulin Derivatives.III. Degree of Protraction, Crystallizability and Chemical Stability of Insulins Substituted in Positions A21, B13, B23, B27 and B30.” Protein Eng. 1988, vol. 2: p. 157-166.
Markussen, et al., “Soluble, Fatty Acid Acylated Insulins Bind to Albumin and Show Protracted Action in Pigs.” Diabetologia, 1996, vol. 39, pp. 281-288.
Miki, H. et al., “Glucagon-like Peptide-1(7-36) Amide Enhances Insulin-stimulated Glucose Uptake and Decreases Intracellular cAMP Content in Isolated Rat Adipocytes.” Biochimica et Biophysica Acta, 1996, pp. 132-136.
Montrose-Rafizadeh, C., et al., “Pancreatic Glucagon-Like Peptide-1 Receptor Couples to Multiple G Proteins and Activates Mitogen-Activated Protein Kinase Pathways in Chinese Hamster Ovary Cells,” Endocrinology, 1999, vol. 140, No. 3, pp. 1132-1140.
Myers, et al., “Acylation of Human Insulin With Palmitic Acid Extends the Time Action of Human Insulin in Diabetic Dogs.” Diabetes, 1997, vol. 46, pp. 637-642.
Vella, et al., “Effects of Glucagon-Like Peptide 1 (7-36) Amide on Glucose Effectiveness and Insulin Action in People With Type 2 Diabetes.” Diabetes, Apr. 2000, vol. 49, pp. 611-617.
Zander, et al., “Additive Glucose-Lowering Effects of Glucagon-Like Peptide-1 and Metformin in Type 2 Diabetes.” Apr. 2001, vol. 24, No. 4, pp. 720-725.
Del Prato, Stefano, et al. “Basal Plasma Insulin Levels Exert a Qualitative But Not Quantitative Effect On Glucose-Mediated Glucose Uptake.” The American Physiological Society, pp. E1089-E1095, 1995.

Affiliated with

Also associated with

Rating

Biphasic mixtures of GLP-1 and insulin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biphasic mixtures of GLP-1 and insulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biphasic mixtures of GLP-1 and insulin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3872762